Conserve cash, don't buy back shares
As stocks plummet, corporates should not make big buybacks to defend their share price
A SIMPLISTIC distinction often made between Western and traditional Chinese medicine is that the former uses scientifically proven methods to treat disease symptoms, while the latter goes for a broader approach to address root causes.
From this perspective, swooning stock markets are just symptoms. It is foolish to attempt to support share prices using artificial means, in the hope that underlying diseases go away.
With valuations at lows, the Singapore Exchange (SGX) has seen a raft of share buyback activity, with around 1,500 such announcements made by companies in the past six months.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Meituan to debut in Riyadh as expansion beyond China quickens
Mapletree Industrial Trust to distribute S$13 million of divestment gains over next 4 quarters
K-pop agency Hybe’s internal strife wipes out 1.2 trillion won
Beijing city to subsidise domestic AI chips, targets self-reliance by 2027
Hong Kong bourse regains favour on hopes of a market revival
Chinese sellers go to TikTok school to reach buyers abroad